These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL, Shen DH, Xue WC, Li Y, Yu YZ. Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [Abstract] [Full Text] [Related]
12. Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: correlation with lymph node status and other clinical pathologic parameters in breast cancer. Midulla C, De Iorio P, Nagar C, Pisani T, Cenci M, Valli C, Nofroni I, Vecchione A. Anticancer Res; 1999 Apr; 19(5B):4033-7. PubMed ID: 10628350 [Abstract] [Full Text] [Related]
13. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression. Berney CR, Yang J, Fisher RJ, Russell PJ, Crowe PJ. Oncol Res; 1998 Apr; 10(1):47-54. PubMed ID: 9613457 [Abstract] [Full Text] [Related]
14. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis]. Liu H, Mao H, Fu X. Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092 [Abstract] [Full Text] [Related]
15. Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival. Nesi G, Palli D, Pernice LM, Saieva C, Paglierani M, Kroning KC, Catarzi S, Rubio CA, Amorosi A. Anticancer Res; 2001 May; 21(5):3643-9. PubMed ID: 11848537 [Abstract] [Full Text] [Related]